The goal of this activity is for learners to be better able to recognize the various treatment settings and associated data evaluating immunotherapy for the care of patients with NSCLC from early to advanced stages.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001937
- Start Date: 2024-11-20 06:00:00
- End Date: 2024-11-20 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- MOC Credit Details: ABIM - 0.75 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Merck & Co. - Amount: 99000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology, Pulmonary Disease
Subscribe
Login
0 Comments
Oldest